carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma [published online April 4, 2018]. Leuk Lymphoma. 2018:1-7. doi: 10.1080/10428194.2018.1443337.
Advertisement
Articles by carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma [published online April 4, 2018]. Leuk Lymphoma. 2018:1-7. doi: 10.1080/10428194.2018.1443337.
Advertisement
Latest Updated Articles
- Study Summary: Ibrutinib Plus Carfilzomib for Relapsed or Relapsed/Refractory Multiple Myeloma
Published: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Energy Insecurity Linked to Higher Depression, Anxiety in US Adults
2
FDA Expands Sotatercept Indication for PAH
3
Patients, Providers Strongly Favor Oral Therapies in Psoriasis
4
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
5
